PTC Therapeutics (PTCT) announced that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher for $150M upon the closing of the transaction. PTC was granted ...

PTC Therapeutics has struck a $150 million deal to sell its Rare Pediatric Disease Priority Review Voucher, awarded by the FDA alongside the approval of KEBILIDI™ for AADC deficiency treatment.

Black Friday 2024 is finally here, and the Post Wanted team, as always, is here all day and night to provide you the best ...

Extra 10% off with the Nike student discount - sales items included ...

Pepe Unchained ($PEPU) is the latest crypto ICO to drop in the crypto landscape, offering plenty of potential and a range of opportunities for early investors seeking ...